Commerce Bank Horizon Therapeutics Public LTD CO Transaction History

Commerce Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $3,464 - $4,050	35 Added 0.74%	4,766 $551,000
Q2 2023 Aug 08, 2023	BUY	$96.34 - $112.38 $232,083 - $270,723	2,409 Added 103.75%	4,731 $486,000
Q1 2023 May 04, 2023	SELL	$107.32 - $113.5 $168,063 - $177,741	-1,566 Reduced 40.28%	2,322 $253,000
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $68,254 - $124,497	-1,094 Reduced 21.96%	3,888 $442,000
Q3 2022 Nov 04, 2022	BUY	$58.92 - $84.67 $14,081 - $20,236	239 Added 5.04%	4,982 $308,000

Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $20,326 - $29,788	256 Added 5.71%	4,743 $378,000
Q1 2022 May 09, 2022	SELL	$86.42 - $109.81 $169,383 - $215,227	-1,960 Reduced 30.4%	4,487 $472,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $887 - $1,079	9 Added 0.14%	6,447 $694,000
Q3 2021 Nov 09, 2021	BUY	$91.91 - $110.37 $329,864 - $396,117	3,589 Added 125.97%	6,438 $705,000
Q2 2021 Aug 09, 2021	BUY	$86.24 - $95.92 $7,761 - $8,632	90 Added 3.26%	2,849 $267,000
Q1 2021 May 05, 2021	BUY	$71.83 - $95.48 $198,178 - $263,429	2,759 New	2,759 $254,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

Stay updated on Commerce Bank with notifications on news.